1. Early identification of refractory epilepsy;Kwan;N Engl J Med,2000
2. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study;Chen;JAMA Neurol,2018
3. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial;Krauss;Lancet Neurol,2019
4. The impact of seizures on epilepsy outcomes: a national, community-based survey;Josephson;Epilepsia,2017
5. Sperling M, Klein P, Kamin M. Safety of cenobamate (YKP3089) as adjunctive treatment for uncontrolled partial seizures in a large, multi-center, open-label study. American Epilepsy Society Annual Meeting; New Orleans, LA; Dec 2, 2018.